Aimei Health Technology Co., Ltd. is a blank check company incorporated in 2023 and headquartered in New York. As a special purpose acquisition company, it was established to identify and execute a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more operating businesses. The company operates within the financial sector as a financial conglomerate, serving as a vehicle for investors seeking exposure to potential merger and acquisition opportunities. Aimei Health Technology Co., Ltd. trades on the Nasdaq under the symbol AFJKR, with rights issued that expire in November 2028. Through its structure, the company provides a mechanism for business consolidation and capital deployment in pursuit of strategic acquisitions and corporate restructuring initiatives.